With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.
Specialty Pharmacy News
AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease.
Walgreens on Thursday announced that effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for Blincyto (blinatumomab).
Price Chopper launched a new specialty pharmacy program, which expands pharmacy services in an effort to provide more convenient and personalized solutions for patients.
Walgreens on Tuesday announced the launch of Well Beyond HIV, a national campaign highlighting people aging well beyond their HIV diagnosis.
Actavis on Tuesday announced the launch of a leading portfolio of generic specialty injectable medications to be marketed to hospitals across the United States.
Shire and NPS Pharmaceuticals have entered into a merger agreement for a total consideration of $5.2 billion.
Vertex Pharmaceuticals has announced that the Food and Drug Administration approved a supplemental new drug application for the use of Kalydeco (ivacaftor) in people with cystic fibrosis ages 6 years and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator gene.
Genentech last week announced that the Food and Drug Administration approved a supplemental biologics license application for Gazyva to be used in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia.
Diplomat Pharmacy has announced that Jennifer Hagerman will take office as the president of the Michigan Pharmacists Association.